ZA200809115B - Use of antisecretory factors for treating intraocular hypertension - Google Patents

Use of antisecretory factors for treating intraocular hypertension

Info

Publication number
ZA200809115B
ZA200809115B ZA200809115A ZA200809115A ZA200809115B ZA 200809115 B ZA200809115 B ZA 200809115B ZA 200809115 A ZA200809115 A ZA 200809115A ZA 200809115 A ZA200809115 A ZA 200809115A ZA 200809115 B ZA200809115 B ZA 200809115B
Authority
ZA
South Africa
Prior art keywords
intraocular hypertension
antisecretory factors
treating intraocular
treating
antisecretory
Prior art date
Application number
ZA200809115A
Other languages
English (en)
Inventor
Hansson Hans-Arne
Stefan Lange
Jennische Eva
Original Assignee
Lantmaennen As Faktor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lantmaennen As Faktor Ab filed Critical Lantmaennen As Faktor Ab
Publication of ZA200809115B publication Critical patent/ZA200809115B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
ZA200809115A 2006-04-27 2008-10-23 Use of antisecretory factors for treating intraocular hypertension ZA200809115B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0600932 2006-04-27

Publications (1)

Publication Number Publication Date
ZA200809115B true ZA200809115B (en) 2009-07-29

Family

ID=38561776

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200809115A ZA200809115B (en) 2006-04-27 2008-10-23 Use of antisecretory factors for treating intraocular hypertension

Country Status (18)

Country Link
US (2) US8207296B2 (cg-RX-API-DMAC7.html)
EP (2) EP2015767B1 (cg-RX-API-DMAC7.html)
JP (2) JP5284948B2 (cg-RX-API-DMAC7.html)
KR (1) KR20090040404A (cg-RX-API-DMAC7.html)
CN (2) CN102633863B (cg-RX-API-DMAC7.html)
AU (1) AU2007244004B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0710959B8 (cg-RX-API-DMAC7.html)
CA (2) CA2771087C (cg-RX-API-DMAC7.html)
DK (2) DK2468292T3 (cg-RX-API-DMAC7.html)
ES (2) ES2561945T3 (cg-RX-API-DMAC7.html)
IL (1) IL194773A (cg-RX-API-DMAC7.html)
MX (1) MX2008013769A (cg-RX-API-DMAC7.html)
NZ (2) NZ572255A (cg-RX-API-DMAC7.html)
PL (2) PL2015767T3 (cg-RX-API-DMAC7.html)
RU (1) RU2458703C2 (cg-RX-API-DMAC7.html)
SG (1) SG171602A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007126364A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200809115B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG171602A1 (en) * 2006-04-27 2011-06-29 Lantmaennen As Faktor Ab Use of antisecretory factors for treating intraocular hypertension
US9962424B2 (en) 2007-04-27 2018-05-08 Lantmännen As-Faktor Ab Use of antisecretory factors (AF) for optimizing cellular uptake
EP2396024A4 (en) * 2009-02-11 2013-02-27 Lantmaennen As Faktor Ab USE OF ANTISECRREATORY FACTORS (AF) FOR OPTIMIZATION OF CELLULAR ABSORPTION
WO2013050795A1 (en) * 2011-10-03 2013-04-11 Femtonics Kft. Use of photoactive compounds
WO2014096384A1 (en) * 2012-12-20 2014-06-26 Lantmännen As-Faktor Ab Use of antisecretory factor (af) in glioblastoma treatment
JP6707121B2 (ja) 2015-07-10 2020-06-10 ラントメネン・アーエス−ファクトール・アーベー 高含量のａｆ−１６を有する卵黄の産生方法
MX2019000594A (es) 2016-07-18 2019-09-09 Lantmaennen As Faktor Ab Factor anti-secretor 17.
JP7217760B2 (ja) 2018-06-28 2023-02-03 ラントメネン・メディカル・アーベー 急性呼吸不全の治療および／または予防の使用のための抗分泌因子
EP3855935A1 (en) 2018-09-28 2021-08-04 Lantmännen Functional Foods AB A consumable product comprising malted wheat
EP3855934A2 (en) 2018-09-28 2021-08-04 Lantmännen Functional Foods AB A consumable product comprising malted dehulled oat
CN115605214A (zh) 2020-03-26 2023-01-13 兰特门内保健食品公司（Se） 用于促进身体活动恢复的包含麦芽化谷物的可消耗产品
WO2024102346A1 (en) * 2022-11-08 2024-05-16 Aisa Pharma, Inc. Methods of treating eye pain and eye disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH682716A5 (de) 1992-01-13 1993-11-15 Christian Fricker Benzo-Pyrone und/oder Dobesilat-Calcium enthaltende pharmazeutische Zusammensetzung.
US5585401A (en) * 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
SE508609C2 (sv) * 1995-08-24 1998-10-19 Rural Patent Svenska Ab Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
JP2000506375A (ja) * 1996-01-26 2000-05-30 エイチエスシー リサーチ アンド デベロップメント リミテッド パートナーシップ アルツハイマー病に関連する核酸およびタンパク質、ならびにその使用
SE506486C2 (sv) * 1996-11-20 1997-12-22 Svenska Lantmaennen Riksfoerbu Födoämne som vid förtäring inducerar antisekretoriska proteiner
SE513496C2 (sv) * 1998-12-17 2000-09-18 Rural Patent Svenska Ab NASP-berikad äggula samt dess användning
MXPA01001885A (es) * 1999-06-21 2002-04-24 Inkine Pharmaceutical Company Angiocidina: un receptor de adhesion a celula tumoral especifico de cys-ser-val-thr-cys-gly.
RU2192898C1 (ru) * 2001-08-16 2002-11-20 Московский научно-исследовательский институт глазных болезней им. Гельмгольца Способ лечения герпетического кератита с изъязвлением
GB0322645D0 (en) * 2003-09-26 2003-10-29 Melacure Therapeutics Ab Use of antisecretory factor peptides
AU2007244005B2 (en) * 2006-04-27 2012-08-02 Lantmannen As-Faktor Ab Further medical uses of antisecretory protein
SG171602A1 (en) * 2006-04-27 2011-06-29 Lantmaennen As Faktor Ab Use of antisecretory factors for treating intraocular hypertension
CN101460187B (zh) * 2006-04-27 2014-11-05 兰特门内阿斯-法克托尔公司 抗分泌蛋白的进一步医疗应用

Also Published As

Publication number Publication date
KR20090040404A (ko) 2009-04-24
CA2771087A1 (en) 2007-11-08
JP2012153695A (ja) 2012-08-16
US20120283191A1 (en) 2012-11-08
NZ572255A (en) 2012-03-30
CN101432013B (zh) 2015-01-07
IL194773A (en) 2015-07-30
US20090162296A1 (en) 2009-06-25
DK2468292T3 (da) 2020-03-23
BRPI0710959A2 (pt) 2012-02-28
CA2650344A1 (en) 2007-11-08
CN101432013A (zh) 2009-05-13
CN102633863A (zh) 2012-08-15
RU2458703C2 (ru) 2012-08-20
AU2007244004A1 (en) 2007-11-08
WO2007126364A2 (en) 2007-11-08
MX2008013769A (es) 2009-02-03
JP2009535329A (ja) 2009-10-01
NZ598426A (en) 2012-08-31
EP2468292B8 (en) 2020-02-26
CA2771087C (en) 2016-03-15
US9000125B2 (en) 2015-04-07
SG171602A1 (en) 2011-06-29
AU2007244004B2 (en) 2012-02-09
IL194773A0 (en) 2011-08-01
DK2015767T3 (en) 2016-02-08
CA2650344C (en) 2017-10-31
CN102633863B (zh) 2014-08-06
JP5284948B2 (ja) 2013-09-11
EP2468292A1 (en) 2012-06-27
BRPI0710959B1 (pt) 2018-11-06
RU2008146733A (ru) 2010-06-10
EP2468292B1 (en) 2019-12-18
EP2015767A2 (en) 2009-01-21
US8207296B2 (en) 2012-06-26
WO2007126364A3 (en) 2008-03-06
PL2015767T3 (pl) 2016-05-31
PL2468292T3 (pl) 2020-08-24
BRPI0710959B8 (pt) 2021-05-25
EP2015767B1 (en) 2016-01-06
ES2773945T3 (es) 2020-07-15
ES2561945T3 (es) 2016-03-01
WO2007126364A8 (en) 2009-07-23

Similar Documents

Publication Publication Date Title
ZA200809115B (en) Use of antisecretory factors for treating intraocular hypertension
EP2324029A4 (en) HETEROCYCLIC HEMMER OF HISTAMINE RECEPTORS FOR DISEASE TREATMENT
EP2320904A4 (en) AMINOPYRIMIDINE INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE
EP2051725A4 (en) METHOD FOR THE TREATMENT OF GRAIN WITH SATURATION FACTORS
IL198851A0 (en) Methods for treating hypercholesterolemia
IL193451A0 (en) Surgical devices for treating pelvic conditions
ZA200810105B (en) Means for controlling the progression of myopia
HUS1600027I1 (hu) Kompozíció pulmonáris hipertensio kezeléséhez
PL2306977T3 (pl) Sposób oraz kompozycja do leczenia nadciśnienia wewnątrzgałkowego i jaskry
EP1993539A4 (en) THIAZOLONE AS A PI3 KINASE INHIBITOR
PL2010717T3 (pl) Sposób obudowy ścian wykopów
GB2446944B (en) Removal of prosthesis
IL207397A0 (en) Difluorobiphenylamide derivtives for the treatment of ocular hypertension
IL198005A0 (en) Ccr2 antagonists for treatment of fibrosis
EP1993535A4 (en) THIAZOLONE AS A PI3 KINASE INHIBITOR
IL198941A0 (en) Isosorbide mononitrate derivatives for the treatment of ocular hypertension
EP1940397A4 (en) METHOD FOR TREATING HYPERTONIA
EP1993537A4 (en) THIAZOLONES AS INHIBITORS OF P13-KINASES
EP1993536A4 (en) THIAZOLONES AS INHIBITORS OF P13-KINASES
EP1996191A4 (en) THIAZOLONE AS A PI3 KINASE INHIBITOR
ZA200807615B (en) Renin inhibitors for the treatment of hypertension
SG121993A1 (en) Process for influencing the properties of combustion residue
EP1993538A4 (en) THIAZOLONES AS INHIBITORS OF P13-KINASES
GB0820885D0 (en) A composition for the treatment of hypertension
EP2056811A4 (en) MODAFINIL TREATMENT AGAINST EARLY EJACULATION